Showing results (101-110 of 861) with videos related to

Sort By:
Pageof 87
Lupus Science & Medicine|February 28, 2023
Clinical associations of cognitive dysfunction in systemic lupus erythematosusSudha Raghunath, Yifat Glikmann-Johnston, Vera Golder, et al.
Lupus Science & Medicine|May 22, 2020
Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosusIleana Vázquez-Otero, Nicolle Medina-Cintrón, Mariangelí Arroyo-Ávila, et al.
Lupus Science & Medicine|February 9, 2023
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)John Conklin, Michael Golpanian, Alexis Engel, et al.
Lupus Science & Medicine|November 17, 2022
Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLEErik W Anderson, Ying Jin, Andrew Shih, et al.
Lupus Science & Medicine|January 12, 2026
Clinical value of simultaneous detection of anti-dsDNA and anti-chromatin antibodies using a multiplex immunoassay in systemic lupus erythematosus: a 5-year retrospective studyThibault Sixt, Daniela Lakomy, Adrien Guilloteau, et al.
Lupus Science & Medicine|October 23, 2025
HDAC3 knockdown inhibits ferroptosis via upregulating Nrf2 to alleviate renal interstitial fibrosis in lupus nephritisTianli Shi, Zhen Luo, Wenjuan Lei
Lupus Science & Medicine|October 30, 2025
Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II studyIvanna Romankevych, Nora Singer, Jennifer Huggins, et al.
Lupus Science & Medicine|October 7, 2025
Predictors of patient-reported outcomes phenotypes in SLE during remission: a cluster analysis approachElena Elefante, Francy Cruz-Sanabria, Luca Gualtieri, et al.
Lupus Science & Medicine|August 2, 2022
Urinary HER2, TWEAK and VCAM-1 levels are associated with new-onset proteinuria in paediatric lupus nephritisPatricia Costa-Reis, Kelly Maurer, Michelle A Petri, et al.
Lupus Science & Medicine|September 17, 2025
Vitamin D receptor expression level in patients with SLE and its relationship with vitamin D status, disease course and bone mineral densitySergii Shevchuk, Tetiana Malovana, Liubov Marynych, et al.
Pageof 87